home / stock / nvs / nvs articles


NVS Articles, Novartis AG - From 09/22/23

Stock Information

Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com

Menu

NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...

From Years to Months: How AI is Shaping the Landscape of Clinical Trials | Benzinga

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially ...

Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories | Benzinga

Bloomberg Amazon Poaches Microsoft's Product Chief Ahead Of Its Annual Devices Event After Microsoft Corp (NASDAQ: MSFT) Chief Produ...

Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact | Benzinga

BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, fr...

Instacart Mulls IPO Price Hike After Arm's Stellar Debut, UAW Launches Historic Simultaneous Strike, China Sanctions Lockheed Martin & Northrop Grumman Concerning Taiwan Arms Sales: Today's Top Stories | Benzinga

Wall Street Journal Instacart Mulls IPO Price Hike After Arm's Stellar Debut: Targeting $10B Valuation Instacart, the popular grocery-delivery...

Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off | Benzinga

At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders approved the proposed 100% spin-off of Sandoz. ...

Qualcomm-Apple Chip Supply Agreement, Report On AstraZeneca CEO's Alleged Intention To Step Down, Apple & Google Face Off in Antitrust Showdown: Today's Top Stories | Benzinga

Benzinga Qualcomm Announces Chip Supply Agreement With Apple Qualcomm Inc (NASDAQ: QCOM) stock is trading higher Monday after the chip design...

Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis | Benzinga

Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has entered a development and commercializatio...

Price Over Earnings Overview: Novartis | Benzinga

In the current market session, Novartis Inc. (NYSE:NVS) share price is at $101.05, after a 0.57% spike. Moreover, over the past month, the stock de...

Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet | Benzinga

The Biden administration's move to lower drug prices has prompted a flurry of legal challenges. While legal experts acknowledge the lack of a c...

Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle | Benzinga

The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's ...

Previous 10 Next 10